755 filings
Page 34 of 38
SC 13G/A
AERI
Aerie Pharmaceuticals Inc
12 Feb 15
Aerie Pharmaceuticals Inc
12:00am
SC 13G/A
AERI
Aerie Pharmaceuticals Inc
10 Feb 15
Aerie Pharmaceuticals Inc
12:00am
SC 13G/A
AERI
Aerie Pharmaceuticals Inc
10 Feb 15
Aerie Pharmaceuticals Inc
12:00am
SC 13G
AERI
Aerie Pharmaceuticals Inc
9 Feb 15
Aerie Pharmaceuticals Inc
12:00am
SC 13G
AERI
Aerie Pharmaceuticals Inc
9 Feb 15
Beneficial ownership report
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
6 Feb 15
Departure of Directors or Certain Officers
12:00am
CT ORDER
AERI
Aerie Pharmaceuticals Inc
23 Jan 15
Confidential treatment order
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
12 Jan 15
Regulation FD Disclosure
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
17 Dec 14
Regulation FD Disclosure
12:00am
SC 13D/A
AERI
Aerie Pharmaceuticals Inc
4 Dec 14
Aerie Pharmaceuticals Inc
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
2 Dec 14
Regulation FD Disclosure
12:00am
SC 13D/A
AERI
Aerie Pharmaceuticals Inc
26 Nov 14
Aerie Pharmaceuticals Inc
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
18 Nov 14
Any discussion of the potential use or expected success of our product candidates is subject to our
12:00am
10-Q
2014 Q3
AERI
Aerie Pharmaceuticals Inc
Quarterly report
12 Nov 14
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
12 Nov 14
Aerie Pharmaceuticals Reports Third Quarter 2014 Financial Results and Provides Business and Product Development Update
12:00am
EFFECT
AERI
Aerie Pharmaceuticals Inc
10 Nov 14
Notice of effectiveness
12:00am
S-3
AERI
Aerie Pharmaceuticals Inc
3 Nov 14
Shelf registration
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
6 Oct 14
Aerie Pharmaceuticals Elects Benjamin F. McGraw, III to Its Board of Directors
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
30 Sep 14
Aerie Announces Closing of $125 Million Convertible Notes Financing
12:00am
8-K
AERI
Aerie Pharmaceuticals Inc
26 Sep 14
Departure of Directors or Certain Officers
12:00am